Higher 25-hydroxyvitamin D levels are associated with greater odds of remission with anti-tumour necrosis factor-α medications among patients with inflammatory bowel diseases

Alimentary Pharmacology and Therapeutics

Volumn 45, Issue 5, 2017, Pages 653-659

  Winter, R W ^a   Collins, E ^a   Cao, B ^a   Carrellas, M ^a   Crowell, A M ^a   Korzenik, J R ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

25 HYDROXYVITAMIN D; ADALIMUMAB; C REACTIVE PROTEIN; INFLIXIMAB; TUMOR NECROSIS FACTOR INHIBITOR; 25-HYDROXYVITAMIN D; TUMOR NECROSIS FACTOR; VITAMIN D;

ADULT; AGE; ARTICLE; CROHN DISEASE; ELECTRONIC MEDICAL RECORD; FEMALE; GENDER; HUMAN; INFLAMMATORY BOWEL DISEASE; LOGISTIC REGRESSION ANALYSIS; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; REMISSION; RISK ASSESSMENT; TREATMENT RESPONSE; ULCERATIVE COLITIS; VITAMIN BLOOD LEVEL; ANALOGS AND DERIVATIVES; ANTAGONISTS AND INHIBITORS; BLOOD; INFLAMMATORY BOWEL DISEASES; MIDDLE AGED; RETROSPECTIVE STUDY; STATISTICAL MODEL; YOUNG ADULT;

ADALIMUMAB; ADULT; FEMALE; HUMANS; INFLAMMATORY BOWEL DISEASES; INFLIXIMAB; LOGISTIC MODELS; MALE; MIDDLE AGED; RETROSPECTIVE STUDIES; TUMOR NECROSIS FACTOR-ALPHA; VITAMIN D; YOUNG ADULT;

EID: 85009453015     PISSN: 02692813     EISSN: 13652036     Source Type: Journal    
DOI: 10.1111/apt.13936     Document Type: Article

References (19)

1. Holick MF. Sunlight and vitamin D for bone health and prevention of autoimmune diseases, cancers, and cardiovascular disease 1–4. Am J Clin Nutr 2004; 80: 1678S–88S.
2. Mouli V, Ananthakrishnan AN. Review article: vitamin D adn inflammatory bowel diseases. Aliment Pharmacol Ther 2014; 39: 125–36.
3. Ulitsky A, Ananthakrishnan AN, Naik A, et al. Vitamin D deficiency in patients with inflammatory bowel disease: association with disease activity and quality of life. JPEN J Parenter Enteral Nutr 2011; 35: 308–16.
4. Ananthakrishnan AN, Khalili H, Higuchi LM, et al. Higher predicted vitamin D status is associated with reduced risk of crohn's disease. Gastroenterology 2012; 142: 482–9.
5. Leslie WD, Miller N, Rogala L, Bernstein CN. Vitamin D status and bone density in recently diagnosed inflammatory bowel disease: the Manitoba IBD Cohort Study. Am J Gastroenterol 2008; 103: 1451–9.
6. Holick MF. Vitamin D deficiency. N Engl J Med 2007; 357: 266–81.
7. Rosen CJ, Vitamin D. Insufficiency. N Engl J Med 2011; 364: 248–54.
8. Ananthakrishnan AN, Cagan A, Gainer VS, et al. Normalization of plasma 25-hydroxy vitamin D is associated with reduced risk of surgery in Crohn's disease. Inflamm Bowel Dis 2013; 19: 1921–7.
9. Reich KM, Fedorak RN, Madsen K, Kroeker KI. Vitamin D improves inflammatory bowel disease outcomes: basic science and clinical review. World J Gastroenterol 2014; 20: 4934–47.
10. Hlavaty T, Krajcovicova A, Koller T, et al. Higher vitamin D serum concentration increases health related quality of life in patients with inflammatory bowel diseases. World J Gastroenterol 2014; 20: 15787–96.
11. Jørgensen SP, Agnholt J, Glerup H, et al. Clinical trial: vitamin D3 treatment in Crohn's disease - a randomized double-blind placebo-controlled study. Aliment Pharmacol Ther 2010; 32: 377–83.
12. Zator ZA, Cantu SM, Konijeti GG, et al. Pretreatment 25-hydroxyvitamin D levels and durability of anti-tumor necrosis factor-α therapy in inflammatory bowel diseases. JPEN J Parenter Enteral Nutr 2014; 38: 385–91.
13. Zhu Y, Mahon B, Froicu M, Cantorna M. Calcium and 1 alpha,25-dihydroxyvitamin D3 target the TNF-alpha pathway to suppress experimental inflammatory bowel disease. Eur J Immunol 2005; 35: 217–24.
14. Froicu M, Cantorna MT. Vitamin D and the vitamin D receptor are critical for control of the innate immune response to colonic injury. BMC Immunol 2007; 8: 5.
15. Miheller P, Muzes G, Hritz I, et al. Comparison of the effects of 1,25 dihydroxyvitamin D and 25 hydroxyvitamin D on bone pathology and disease activity in Crohn's disease patients. Inflamm Bowel Dis 2009; 15: 1656–62.
16. Aranow C. Vitamin D and the immune system. J Investig Med 2011; 59: 881–6.
17. Calton EK, Keane KN, Newsholme P, Soares MJ. The impact of Vitamin D levels on inflammatory status: a systematic review of immune cell studies. PLoS ONE 2015; 10: 1–12.
18. Wang TT, Dabbas B, Laperriere D, et al. Direct and indirect induction by 1,25-dihydroxyvitamin D3 of the NOD2/CARD15-defensin β2 innate immune pathway defective in crohn disease. J Biol Chem 2010; 285: 2227–31.
19. Dionne S, Calderon MR, White JH, et al. Differential effect of vitamin D on NOD2- and TLR-induced cytokines in Crohn's disease. Mucosal Immunol 2014; 7: 1405–15.